This page contains a complete list of all FDA analyses conducted in the Sentinel System from the start of Mini-Sentinel in 2009 to the present.
The table below is organized at the individual analysis level (e.g., Level 1, Level 2, Query Builder, protocol-based assessment, etc.). It is designed to support searches for a specific analysis.
Alternatively, the Drug Studies table groups together related analyses that FDA conducted to address a safety concern, or set of related safety concerns. The Drug Studies page also provides important background information and describes the regulatory impact.
Note: The appearance of a drug in a Sentinel study does not mean that FDA has concluded that a causal relationship exists between the drug and the health outcome of interest. Patients and healthcare providers should refer to FDA.gov for further information about drug safety.
FDA Sentinel Analyses from ARIA and Other Sentinel Data Sources
Loading...
| Title | Medical Product | Outcomes | Date |
|---|---|---|---|
| Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers Linked to Live-Birth Deliveries in the Mother-Infant Linkage Table: A Descriptive Analysis Exploratory Analyses |
products for the development of the pregnancy safety study framework
|
use in pregnancy |
09/15/2023 |
| Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis Exploratory Analyses |
products for the development of the pregnancy safety study framework
|
use in pregnancy |
09/15/2023 |
| Baloxavir and Oseltamivir Utilization: A Descriptive Analysis Exploratory Analyses |
baloxavir, oseltamivir
|
08/18/2023 | |
| Bevacizumab and Other Cancer Medication Use in Pregnant Patients: A Descriptive Analysis Exploratory Analyses |
bevacizumab, pegaptanib, ranibizumab, verteporfin
|
08/04/2023 | |
| Incident Utilization of Allopurinol, Hydralazine, and Propylthiouracil: A Descriptive Analysis Exploratory Analyses |
allopurinol, hydralazine, propylthiouracil
|
07/31/2023 | |
| Incident Utilization Patterns of Obesity Drugs: A Descriptive Analysis Exploratory Analyses |
obesity drugs
|
07/26/2023 | |
| Utilization and Switching Patterns of Mixed Amphetamine Salt (MAS) Products in Patients with Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy: A Descriptive Analysis Exploratory Analyses |
mixed amphetamine salts
|
switching patterns |
07/25/2023 |
| Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis Exploratory Analyses |
beta blockers
|
07/19/2023 | |
| Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis Exploratory Analyses |
beta blockers
|
07/19/2023 | |
| Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses Exploratory Analyses |
cannabis-derived products
|
07/19/2023 | |
| Baricitinib or Tocilizumab Use in Hospitalized Patients with a COVID-19 Diagnosis: A Descriptive Analysis Exploratory Analyses |
baricitinib, tocilizumab
|
emergency use authorization , utilization |
07/18/2023 |
| Prevalence and Characterization of Pharmacogenetic Testing Healthcare Common Procedure Coding System (HCPCS) Procedure Codes in the Mini-Sentinel Distributed Database (MSDD): A Descriptive Analysis Exploratory Analyses |
pharmacogenetic testing
|
07/14/2023 | |
| Dupixent (Dupilumab) Utilization Patterns: A Descriptive Analysis Exploratory Analyses |
dupilumab dupixent
|
07/10/2023 | |
| Alosetron and Eluxadoline Use: A Descriptive Analysis Exploratory Analyses |
alosetron, eluxadoline
|
07/06/2023 | |
| Renal Cell Carcinoma Following Canagliflozin Use in Patients with Type 2 Diabetes: A Descriptive Analysis Exploratory Analyses |
canagliflozin
|
renal cell carcinoma |
07/06/2023 |
| Outcome Monitoring Following Erenumab Use: A Signal Identification Analysis Exploratory Analyses |
erenumab
|
06/22/2023 | |
| Mortality Following Long-Acting Injectable Antipsychotics Use in Patients with Dementia: An Inverse Probability of Treatment Weighting Analysis Safety Analyses |
long-acting injectable antipsychotics
|
mortality |
06/08/2023 |
| Biologics Use in Adults with Ulcerative Colitis: A Descriptive Analysis Exploratory Analyses |
adalimumab, golimumab, infliximab, vedolizumab
|
05/24/2023 | |
| Ischemic Colitis Following Alosetron Use: A Descriptive Analysis Exploratory Analyses |
alosetron
|
ischemic colitis |
05/24/2023 |
| Utilization and Switching Patterns of Inhaled Corticosteroid/Long Acting Beta Agonist and Advair Diskus in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Descriptive Analysis Exploratory Analyses |
Advair Diskus, fluticasone salmeterol
|
brand to generic switching |
05/04/2023 |
| Brand to Generic Switching Patterns Among Advair Diskus Users with Asthma or Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis Exploratory Analyses |
Advair Diskus, fluticasone salmeterol
|
brand to generic switching |
05/01/2023 |
| Insulin Coding Practices: A Descriptive Analysis Exploratory Analyses |
insulin
|
04/27/2023 | |
| Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: An Updated Propensity Score Matched Analysis Safety Analyses |
sacubitril/valsartan
|
angioedema |
04/21/2023 |
| Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis Safety Analyses |
sacubitril/valsartan
|
angioedema |
04/21/2023 |
| Use of Gonadotropin-Releasing Hormone (GnRH) Agonists in Patients with Gender Dysphoria: A Descriptive Analysis Exploratory Analyses |
gonadotropin-releasing hormone agonists
|
duration of use |
04/13/2023 |
| Utilization of Select Products for Migraine Treatment and Prevention: A Descriptive Analysis Exploratory Analyses |
eptinezumab, erenumab-aooe, fremanezumab, galcanezumab, rimegepant, ubrogepant
|
03/22/2023 | |
| Utilization of Select Biological Products: A Descriptive Analysis Exploratory Analyses |
Avastin (bevacizumab), Epogen (epoetin alfa), Inflectra (infliximab-dyyb), Mvasi (bevacizumab-awwb), Neupogen (filgrastim), Remicade (infliximab), Renflexis (infliximab-abda), Retacrit (epoetin alfa-epbx), Zarxio (filgrastim-sndz), Zirabev (bevacizumab-bvzr)
|
03/20/2023 | |
| Outcome Monitoring Following Zarxio Use: An Updated Signal Identification Analysis Exploratory Analyses |
Zarxio (filgrastim-sndz)
|
03/08/2023 | |
| Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Safety Analyses |
fingolimod
|
all congenital malformations , congenital cardiac malformations (primary) , congenital urinary malformations (primary) |
03/03/2023 |
| Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Safety Analyses |
fingolimod
|
all congenital malformations , congenital cardiac malformations (primary) , congenital urinary malformations (primary) |
03/03/2023 |
| Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: A Descriptive Analysis Safety Analyses |
dehydrated alcohol
|
atrioventricular block , heart failure , permanent pacemaker placement , septal myectomy , ventricular arrhythmia |
02/09/2023 |
| Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: An Updated Descriptive Analysis Safety Analyses |
dehydrated alcohol
|
atrioventricular block , heart failure , myocardial infarction , permanent pacemaker placement , septal myectomy , ventricular arrhythmia |
02/09/2023 |
| Characterization of Patients and Encounters in the TriNetX Live USA Network: A Descriptive Analysis Exploratory Analyses |
01/12/2023 | ||
| Identifying Potential Risk Factors for Respiratory Failure: A Descriptive Analysis Exploratory Analyses |
acute respiratory failure |
01/10/2023 | |
| Exploring Claims-Based Definitions of, and Characterizing Patients with, Respiratory Failure: A Descriptive Analysis Exploratory Analyses |
acute respiratory failure |
01/10/2023 | |
| Utilization of Ixekizumab in Pregnant Patients: A Descriptive Analysis Exploratory Analyses |
ixekizumab
|
11/14/2022 | |
| Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis Exploratory Analyses |
Ozempic (semaglutide)
|
11/10/2022 | |
| Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis Exploratory Analyses |
Zarxio (filgrastim-sndz)
|
11/10/2022 | |
| Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis in TriNetX Exploratory Analyses |
ibrexafungerp
|
10/31/2022 | |
| Fractures Following Leuprolide Acetate Use: A Multiple Factor Matched Analysis Safety Analyses |
leuprolide acetate
|
any fracture , hip replacement , major fracture (primary) , temporomandibular joint replacement |
09/16/2022 |
| Fractures Following Leuprolide Acetate Use: A Multiple Factor Matched Analysis (A Follow-up to a Previous Analysis) Safety Analyses |
leuprolide acetate
|
any fracture , hip replacement , major fracture (primary) , temporomandibular joint replacement |
09/16/2022 |
| Comparative Effectiveness of Azithromycin Relative to Roflumilast in Individuals With Uncontrolled Chronic Obstructive Pulmonary Disease Despite Triple Inhaled Therapy Exploratory Analyses |
azithromycin, roflumilast
|
hospitalization and death |
09/01/2022 |
| Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: An Updated Descriptive Analysis Exploratory Analyses |
bamlanivimab, bamlanivimab etesevimab, casirivimab imdevimab
|
utilization |
08/24/2022 |
| Differences in COVID-19 Testing, Positivity, Hospitalization, and Mortality by Race and Ethnicity in the Sentinel Distributed Database: A Descriptive Analysis Exploratory Analyses |
08/19/2022 | ||
| Utilization of Obesity Drugs: A Descriptive Analysis Exploratory Analyses |
obesity drugs
|
08/05/2022 | |
| Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive Analysis Exploratory Analyses |
bamlanivimab, bamlanivimab etesevimab, casirivimab imdevimab, sotrovimab
|
anaphylaxis , hospitalization |
07/14/2022 |
| Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive Analysis Exploratory Analyses |
obesity drugs, sodium-glucose co-transporter-2 (SGLT-2) inhibitor
|
07/11/2022 | |
| Seizures Following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis Safety Analyses |
gadolinium-based contrast agents (GBCA)
|
seizure |
06/29/2022 |
| Tacrolimus Use in Patients Following Liver or Kidney Transplants: A Descriptive Analysis Exploratory Analyses |
tacrolimus
|
06/24/2022 | |
| Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis Exploratory Analyses |
bamlanivimab, bamlanivimab etesevimab, casirivimab imdevimab
|
utilization |
06/24/2022 |
| Count and Duration of Follow up of New-Onset Cancer: An Updated Descriptive Analysis Exploratory Analyses |
duration of follow up |
06/23/2022 | |
| Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis Safety Analyses |
06/21/2022 | ||
| Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis Exploratory Analyses |
bamlanivimab, bamlanivimab etesevimab, casirivimab imdevimab
|
utilization |
06/14/2022 |
| Outpatient Corticosteroid Use in Patients With COVID-19: An Updated Descriptive Analysis Exploratory Analyses |
corticosteroids
|
06/02/2022 | |
| Outpatient Corticosteroid Use in Patients With COVID-19: A Descriptive Analysis Exploratory Analyses |
corticosteroids
|
06/01/2022 | |
| Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease or Ulcerative Colitis: A Descriptive Analysis Exploratory Analyses |
ustekinumab
|
serious infection (Crohn’s disease) , serious infection (ulcerative colitis) |
05/17/2022 |
| Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis Exploratory Analyses |
05/16/2022 | ||
| Death Data Exploration: A Descriptive Analysis Exploratory Analyses |
04/28/2022 | ||
| Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis Exploratory Analyses |
apixaban, dabigatran, rivaroxaban
|
gastrointestinal bleeding , intracranial hemorrhage , major extracranial bleeding , thromboembolic stroke |
04/25/2022 |
| Incidence and Prevalence of Confounding Variables Over Time in the Sentinel Distributed Database (SDD): A Descriptive Analysis Exploratory Analyses |
04/21/2022 | ||
| Duration of Follow Up for New Molecular Entities Approved in 2018: A Descriptive Analysis Exploratory Analyses |
new molecular entities (NMEs)
|
04/20/2022 | |
| Counts and Characteristics of Individuals With Drug-Device Combination Use: A Descriptive Analysis Exploratory Analyses |
drug device combinations
|
04/18/2022 | |
| Utilization of Brodalumab: A Descriptive Analysis Exploratory Analyses |
brodalumab
|
04/05/2022 | |
| Estimated Prevalence of Glomerular Diseases: An Updated Descriptive Analysis Exploratory Analyses |
glomerular diseases |
03/29/2022 | |
| Estimated Prevalence of Glomerular Diseases: A Descriptive Analysis Exploratory Analyses |
glomerular diseases |
03/29/2022 | |
| Hydroxyurea Use Among Patients with Sickle Cell Disease (SCD): A Descriptive Analysis Exploratory Analyses |
hydroxyurea
|
03/29/2022 | |
| Epidiolex (prescription cannabidiol) Utilization Patterns: A Descriptive Analysis Exploratory Analyses |
Epidiolex (prescription cannabidiol)
|
03/28/2022 | |
| Valganciclovir Use in Children with Congenital Cytomegalovirus Disease (cCMV) or Cytomegalovirus (CMV) Infection: A Descriptive Analysis Exploratory Analyses |
valganciclovir
|
congenital cmv |
03/25/2022 |
| Incident and Prevalent Use of Loop Diuretics: A Descriptive Analysis Exploratory Analyses |
loop diuretics
|
03/23/2022 | |
| Human Epidermal Growth Factor Receptor 2 (HER2) Antagonist Use in Patients with Live Birth Deliveries: A Descriptive Analysis Exploratory Analyses |
HER2 antagonists
|
03/11/2022 | |
| Drug Utilization Over Time for Six Drug Classes Exploratory Analyses |
ace inhibitors, beta blockers, granulocyte colony-stimulating factor (GC-SF), intravenous (IV) iron, statins, tumor necrosis factor (TNF) alpha inhibitor
|
03/09/2022 | |
| Mometasone Furoate Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis Exploratory Analyses |
mometasone sinus implant
|
03/03/2022 | |
| Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis Exploratory Analyses |
valsartan
|
03/01/2022 | |
| Bleeding Events and Venous Thromboembolism (VTE) following Enoxaparin Use: A Descriptive Analysis Exploratory Analyses |
enoxaparin
|
hospitalized bleeding , major bleeding , venous thromboembolism (VTE) |
02/25/2022 |
| Tofacitinib, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and Tumor Necrosis Factor Inhibitors (TNFi) Use: A Descriptive Analysis Exploratory Analyses |
disease-modifying anti-rheumatic drugs (DMARDs), tofacitinib, tumor necrosis factor inhibitors (TNFi)
|
02/24/2022 | |
| N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis Exploratory Analyses |
valsartan
|
02/18/2022 | |
| Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis Exploratory Analyses |
new molecular entities (NMEs)
|
01/26/2022 | |
| Duration of Follow Up for New Molecular Entities Approved in 2017: An Updated Descriptive Analysis Exploratory Analyses |
new molecular entities (NMEs)
|
01/21/2022 | |
| Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis Safety Analyses |
sertraline
|
hospitalized depression , intentional self-harm |
12/15/2021 |
| Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis) Safety Analyses |
sertraline
|
hospitalized depression , intentional self-harm |
12/15/2021 |
| Racial Differences in COVID-19 Outcomes (2020-2021) Exploratory Analyses |
Critical COVID-19 , death , hospitalization with COVID-19 |
12/08/2021 | |
| Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis Exploratory Analyses |
alemtuzumab, cladribine, dalfampridine, dimethyl fumarate, diroximel fumarate, fingolimod, glatiramer acetate, interferon beta-1A, interferon beta-1B, mitoxantrone, natalizumab, ocrelizumab, peginterferon beta-1a, siponimod, teriflunomide
|
10/20/2021 | |
| Oral Metoclopramide Use: A Descriptive Analysis Exploratory Analyses |
metoclopramide
|
09/30/2021 | |
| Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) that Employ Elements to Assure Safe Use (ETASU) Exploratory Analyses |
drugs with REMS that employ ETASU
|
08/23/2021 | |
| Duration of Follow Up for New Molecular Entities Approved in 2017: A Descriptive Analysis Exploratory Analyses |
new molecular entities (NMEs)
|
08/13/2021 | |
| Brand and Generic Tacrolimus Use following Kidney, Heart, and Liver Transplants: A Descriptive Analysis Exploratory Analyses |
tacrolimus
|
08/11/2021 | |
| Incidence Rate of Severe Uterine Bleeding Among New Users of Oral Anticoagulants: A Descriptive Analysis Exploratory Analyses |
apixaban, dabigatran, oral anticoagulant, rivaroxaban, warfarin
|
severe uterine bleed |
05/18/2021 |
| Utilization of Sacubitril/Valsartan: A Descriptive Analysis Exploratory Analyses |
sacubitril/valsartan
|
04/19/2021 | |
| Patterns in Insulin Product Use and Billing Codes: A Descriptive Analysis Exploratory Analyses |
insulin
|
04/16/2021 | |
| Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 Exploratory Analyses |
new molecular entities (NMEs)
|
04/16/2021 | |
| Duration of Follow Up for New Molecular Entities Approved in 2011 Exploratory Analyses |
new molecular entities (NMEs)
|
04/16/2021 | |
| Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 Exploratory Analyses |
new molecular entities (NMEs)
|
04/16/2021 | |
| Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 Exploratory Analyses |
new molecular entities (NMEs)
|
04/16/2021 | |
| Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 Exploratory Analyses |
new molecular entities (NMEs)
|
04/16/2021 | |
| Duration of Follow Up for New Molecular Entities Approved in 2016 Exploratory Analyses |
new molecular entities (NMEs)
|
04/16/2021 | |
| Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis Exploratory Analyses |
guselkumab, risankizumab, tildrakizumab
|
lymphoma |
03/30/2021 |
| Angioedema following Dipeptidyl Peptidase IV (DPP IV) Inhibitors and Angiotensin Converting Enzyme (ACE) Inhibitors Use: A Descriptive Analysis Exploratory Analyses |
angiotensin-converting enzyme (ACE) inhibitor, dipeptidyl peptidase-IV (DPP-IV) inhibitor
|
angioedema |
03/26/2021 |
| Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive Analysis Exploratory Analyses |
combined hormonal contraceptives (CHCs), ethinyl estradiol (EE), NuvaRing
|
arterial thromboembolism (ATE) , venous thromboembolism (VTE) |
03/25/2021 |
| Counts of Individuals in the Sentinel Distributed Database Exploratory Analyses |
03/22/2021 | ||
| Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Exploratory Analyses |
03/11/2021 | ||
| Pregnancy among Women with Heart Failure: A Descriptive Analysis Exploratory Analyses |
pregnancy |
03/07/2021 | |
| Serious Infections among Immunocompromised Health Plan Members Exploratory Analyses |
serious infection |
02/24/2021 | |
| Cutaneous Small-Vessel Vasculitis following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis Safety Analyses |
apixaban, dabigatran, direct oral anticoagulant (DOAC), rivaroxaban, warfarin
|
cutaneous small-vessel vasculitis |
02/03/2021 |
| Direct Oral Anticoagulants (DOACs), Warfarin, Allopurinol, or Propylthiouracil Use in Patients with Cutaneous Small-Vessel Vasculitis: A Descriptive Analysis Exploratory Analyses |
allopurinol, direct oral anticoagulant (DOAC), propylthiouracil, warfarin
|
cutaneous small-vessel vasculitis |
02/03/2021 |
| Prevalent and Incident Drug Use in a Pediatric Population: A Descriptive Analysis Exploratory Analyses |
acetaminophen with codeine, acyclovir, acyclovir sodium, albuterol, albuterol sulfate, levalbuterol HCL, levalbuterol tartrate, nitazoxanide, nizatidine, oxycodone HCL, sucralfate
|
01/11/2021 | |
| Abacavir, Carbamazepine, Clopidogrel, and Phenytoin Use: A Descriptive Analysis Exploratory Analyses |
abacavir, carbamazepine, clopidogrel, phenytoin
|
01/04/2021 | |
| Incidence of Acute Respiratory Failure (ARF) following Trimethoprim-Sulfamethoxazole (TMP-SMX) Use: A Descriptive Analysis Exploratory Analyses |
trimethoprim-sulfamethoxazole
|
acute respiratory failure |
12/21/2020 |
| Thrombotic Events and Death in Inpatient-Identified COVID-19 Patients Exploratory Analyses |
thrombotic events |
12/21/2020 | |
| Thrombotic Events in COVID-19 Patients Not Requiring Hospitalization at the Time of Diagnosis Exploratory Analyses |
thrombotic events |
11/24/2020 | |
| Ustekinumab Dispensing Patterns: A Descriptive Analysis Safety Analyses |
ustekinumab
|
11/24/2020 | |
| Risk of Congenital Cardiac Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Safety Analyses |
armodafinil, modafinil
|
congenital cardiac malformations |
11/17/2020 |
| Risk of Congenital Cardiac Malformations Following Armodafinil or Modafinil Use: A Descriptive Analysis Safety Analyses |
armodafinil, modafinil
|
congenital cardiac malformations |
11/17/2020 |
| Counts of Individuals with Gout Using Urate-Lowering Therapy (ULT) and Switching between ULT Products: A Descriptive Analysis Exploratory Analyses |
allopurinol, febuxostat
|
11/12/2020 | |
| Incidence of Severe Uterine Bleed Following Novel Oral Anticoagulants Use: A Descriptive Analysis Exploratory Analyses |
apixaban, dabigatran, rivaroxaban, warfarin
|
severe uterine bleed |
11/09/2020 |
| Mini-Sentinel: Diabetic Ketoacidosis following Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors, Sulfonylureas, Saxagliptin, and Sitagliptin Use: A Descriptive Analysis Safety Analyses |
saxagliptin, sitagliptin, sodium-glucose cotransporter-2 (SGLT-2) inhibitor, sulfonylurea
|
diabetic ketoacidosis |
11/09/2020 |
| Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis Safety Analyses |
apixaban, dabigatran, non-vitamin K antagonist oral anticoagulants, rivaroxaban
|
gastrointestinal bleeding , intracranial hemorrhage , major extracranial bleeding , thromboembolic stroke |
10/29/2020 |
| Wrong Frequency Errors with Low Dose Oral Methotrexate Safety Analyses |
methotrexate
|
09/16/2020 | |
| Acute Myocardial Infarction and Heart Failure following Saxagliptin or Sitagliptin Use: A Propensity Score Matched Analysis Safety Analyses |
long-acting insulin, pioglitazone, saxagliptin, second-generation sulfonylurea, sitagliptin
|
acute myocardial infarction (AMI) , heart failure |
09/15/2020 |
| Factors Related to the Assignment of Sodium Glucose Cotransporter-2 Inhibitors (SGLT-2i) versus Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) Exploratory Analyses |
sodium-glucose cotransporter-2 (SGLT-2) inhibitor
|
factors for treatment assignment |
09/15/2020 |
| Frequency of Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) and Estimated Incidence Rates of Post-PTSMA Cardiovascular Outcomes: A Descriptive Analysis Exploratory Analyses |
percutaneous transluminal septal myocardial ablation |
09/15/2020 | |
| Stroke, Intracranial Hemorrhage, and Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients Aged 65 or Older: A Propensity Score Matched Analysis Exploratory Analyses |
apixaban, dabigatran, rivaroxaban
|
bleeding event , intracranial hemorrhage , stroke |
09/14/2020 |
| Cutaneous Small-Vessel Vasculitis following Direct Oral Anticoagulants (DOACs), Warfarin, or Allopurinol Use in Patients with Atrial Fibrillation: A Descriptive Analysis Exploratory Analyses |
allopurinol, direct oral anticoagulant (DOAC), warfarin
|
cutaneous small-vessel vasculitis |
09/13/2020 |
| Same Day Seizures following Gadolinium Based Contrast Agents: A Self-Controlled Risk Interval Analysis Safety Analyses |
gadolinium-based contrast agent (GBCA)
|
seizure |
09/11/2020 |
| Ranitidine Drug Utilization Patterns Exploratory Analyses |
ranitidine
|
09/03/2020 | |
| Intravenous (IV) Iron Utilization Among Pregnant Women Exploratory Analyses |
intravenous (IV) iron
|
09/01/2020 | |
| Algorithms to Estimate Start of Pregnancy Using In-Vitro Fertilization (IVF), Intrauterine Insemination (IUI), and Select Prenatal Tests among Pregnancies Resulting in a Live-Born Delivery Exploratory Analyses |
08/27/2020 | ||
| Mini-Sentinel: Availability of International Normalized Ratio (INR) Laboratory Test Values and INR Test Procedures among New Warfarin Users Exploratory Analyses |
warfarin
|
08/27/2020 | |
| Spironolactone Use in Patients with Reduced Ejection Fraction Heart Failure (HFrEF) or Preserved Ejection Fraction Heart Failure (HFpEF) Exploratory Analyses |
spironolactone
|
08/25/2020 | |
| Sacubitril/Valsartan, Angiotensin-Converting Enzyme (ACE) Inhibitors, and Other Angiotensin II Receptor Blockers (ARBs) Use in Patients with Heart Failure Exploratory Analyses |
angiotensin II receptor blocker (ARB), angiotensin-converting enzyme (ACE) inhibitor, sacubitril/valsartan
|
08/25/2020 | |
| Mini-Sentinel: Switching Between Generic and Brand Clonazepam Exploratory Analyses |
clonazepam
|
08/25/2020 | |
| Glaucoma, Cataracts, Diminished Visual Acuity, and Nasal Septal Perforation following Mometasone Sinus Implant Use in Patients with Nasal Polyposis: A Descriptive Analysis Safety Analyses |
cataracts , diminished visual acuity , glaucoma , nasal septal perforation |
08/04/2020 | |
| Hypertension in Pediatric Patients: A Descriptive Analysis Exploratory Analyses |
hypertension |
07/23/2020 | |
| Use of Typical and Atypical Antipsychotics Among Infants Exploratory Analyses |
antipsychotic, atypical antipsychotic, typical antipsychotic
|
05/19/2020 | |
| Characterization of SGLT-2 Inhibitor Users in the Patient-Centered Clinical Research Network (PCORnet) Exploratory Analyses |
sitagliptin, sodium-glucose cotransporter-2 (SGLT-2) inhibitor
|
03/19/2020 | |
| Non-Melanoma Skin Cancer following Hydrochlorothiazide Use: A Propensity Score Matched Analysis Safety Analyses |
hydrochlorothiazide (HCTZ)
|
non-melanoma skin cancer |
03/04/2020 |
| Total Enrollment with Medical and Drug Coverage Exploratory Analyses |
02/19/2020 | ||
| Trends in Penicillin Allergy Testing Exploratory Analyses |
penicillin allergy test
|
01/30/2020 | |
| Time Until Guillain-Barré Syndrome or Bell's Palsy Diagnosis following Initiation of Checkpoint Inhibitor Treatment Exploratory Analyses |
atezolizumab, avelumab, durvalumab, ipilimumab, nivolumab, pembrolizumab
|
Bell’s palsy , Guillain-Barré syndrome |
01/24/2020 |
| Prenatal Tests in Women with Potential Stillbirths Exploratory Analyses |
prenatal tests
|
stillbirth |
01/23/2020 |
| Concurrent Use of Ticagrelor with Atorvastatin or Rosuvastatin Exploratory Analyses |
atorvastatin, rosuvastatin, ticagrelor
|
01/23/2020 | |
| Duration of Follow-up for Individuals with Chronic Conditions Exploratory Analyses |
Alzheimer's disease , acquired hypothyroidism , acute myocardial infarction (AMI) , anemia , asthma , atrial fibrillation , benign prostatic hyperplasia , breast cancer , bronchiectasis , chronic conditions , chronic kidney disease (CKD) , chronic obstructive pulmonary disease , colorectal cancer , depression , diabetes , endometrial cancer , glaucoma , heart failure , hyperlipidemia , hypertension , ischemic heart disease , lung cancer , osteoarthritis , osteoporosis , prostate cancer , rheumatoid arthritis , stroke , transient ischemic attack (TIA) |
01/23/2020 | |
| Use of Metoclopramide among Patients with Diabetic Gastroparesis and Type 2 Diabetes Exploratory Analyses |
metoclopramide HCL
|
duration of use |
01/13/2020 |
| Hydroxyurea Use in Patients with Sickle Cell Anemia Exploratory Analyses |
hydroxyurea
|
sickle cell anemia , use by indication |
01/07/2020 |
| Mini-Sentinel: Summary of Antidiabetic Agent Use During Pregnancy Exploratory Analyses |
alpha-glucosidase inhibitor, amylin analog, biguanide, dipeptidyl peptidase-4 (DPP-4) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, injectable insulin, meglitinide analog, sulfonylurea, thiazolidinedione
|
exposure in pregnancy |
01/02/2020 |
| Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel System Exploratory Analyses |
respiratory syncytial virus (RSV) , respiratory syncytial virus-associated illness |
12/06/2019 | |
| Estimating Optimal Quantities for Initial Opioid Analgesic Prescriptions for Acute Pain Conditions Presenting to Surgical Settings Exploratory Analyses |
opioid analgesic
|
drug refill probability |
11/20/2019 |
| Respiratory Syncytial Virus in a Pediatric Population Exploratory Analyses |
respiratory syncytial virus (RSV) |
11/18/2019 | |
| Hydroxyprogesterone Caproate and Progesterone Use During Pregnancy Exploratory Analyses |
hydroxyprogesterone caproate, progesterone
|
exposure in pregnancy |
10/28/2019 |
| Neuropsychiatric Events Following Montelukast Use: A Propensity Score Matched Analysis Safety Analyses |
montelukast
|
inpatient depressive disorder , outpatient depressive disorder , self-harm , suicide |
09/26/2019 |
| Multiple Sclerosis Relapses among Copaxone, Glatopa, Gilenya, and Glatiramer Users Exploratory Analyses |
Copaxone, Gilenya, glatiramer, Glatopa
|
multiple sclerosis relapse |
09/16/2019 |
| Cutaneous Small Vessel Vasculitis and Acute Kidney Injury Following Direct-Acting Oral Anticoagulant Use Exploratory Analyses |
direct oral anticoagulant (DOAC)
|
acute kidney injury , cutaneous small-vessel vasculitis |
09/15/2019 |
| Non-Melanoma Skin Cancer following Hydrochlorothiazide Use Exploratory Analyses |
bendroflumethiazide (BFMTZ), chlorothiazide (CTZ), hydrochlorothiazide (HCTZ)
|
non-melanoma skin cancer |
09/12/2019 |
| Sinus Stents with Mometasone and Diminished Visual Acuity Safety Analyses |
intranasal steroid, mometasone, oral steroid, sinus stent
|
blindness , cataract surgery , cataracts , diminished visual acuity , glaucoma |
09/12/2019 |
| Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) in a Pediatric Population Exploratory Analyses |
angiotensin receptor blocker, angiotensin-converting enzyme (ACE) inhibitor
|
08/22/2019 | |
| Utilization Patterns of Qsymia (Phentermine/Topiramate) Exploratory Analyses |
phentermine HCl, phentermine/topiramate, Qsymia, topiramate
|
08/06/2019 | |
| Use of Higher Dosage Strength Oral and Transmucosal Opioid Analgesics Exploratory Analyses |
higher dosage strength opioid analgesic, lower dosage strength opioid analgesic, opioid analgesic, oral opioid analgesic, transdermal opioid analgesic, transmucosal opioid analgesic
|
07/31/2019 | |
| Ischemic Stroke, Intracranial Hemorrhage, and Gastrointestinal Hemorrhage Among New Users of Apixaban and Warfarin Exploratory Analyses |
apixaban, warfarin
|
gastrointestinal hemorrhage , intracranial hemorrhage , ischemic stroke |
07/09/2019 |
| Use of Korlym and Mifeprex (Mifepristone) Exploratory Analyses |
Korlym, Mifeprex, mifepristone
|
06/24/2019 | |
| Antiemetic Use During Pregnancy Exploratory Analyses |
doxylamine, granisetron, metoclopramide HCL, netupitant/palonosetron HCl, ondansetron, palonosetron, prochlorperazine, promethazine HCl, succinate/pyridoxine HCl
|
exposure in pregnancy |
06/23/2019 |
| Use of Valsartan, Angiotensin II Receptor Blockers (ARB), and Angiotensin-Converting Enzyme (ACE) Inhibitors Exploratory Analyses |
angiotensin II receptor blocker (ARB), angiotensin-converting enzyme (ACE) inhibitor, azilsartan medoxomil, candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan
|
06/05/2019 | |
| New Users of Oral Bisphosphonates Exploratory Analyses |
bisphosphonate
|
05/08/2019 | |
| Neuropsychiatric Events following Montelukast Use Exploratory Analyses |
inhaled corticosteroid, montelukast, nasal corticosteroid, zafirlukast
|
neuropsychiatric event , psychotropic medication use , suicide |
04/22/2019 |
| Duration of Use Among New Users of Hydrochlorothiazide (HCTZ), Angiotensin-Converting Enzyme Inhibitors (ACEIs), and Angiotensin II Receptor Blockers (ARBs) Exploratory Analyses |
angiotensin II receptor blocker (ARB), angiotensin-converting enzyme (ACE) inhibitor, hydrochlorothiazide (HCTZ)
|
04/19/2019 | |
| Severe Uterine Bleed Following Novel Oral Anticoagulants Use: A Propensity Score Analysis Safety Analyses |
apixaban, dabigatran, novel oral anticoagulant (NOAC), rivaroxaban, warfarin
|
severe uterine bleed |
04/17/2019 |
| Leuprolide Acetate Use Among Patients with Central Precocious Puberty Exploratory Analyses |
leuprolide acetate
|
central precocious puberty |
04/15/2019 |
| Gadolinium-Based Contrast Agents (GBCAs) Use in Pregnancy Safety Analyses |
gadolinium-based contrast agent (GBCA)
|
exposure in pregnancy |
04/04/2019 |
| Duration of Follow-Up and Treatment for Non-Insulin Antidiabetic Drugs Exploratory Analyses |
non-insulin antidiabetics
|
04/02/2019 | |
| Dolutegravir Use During Pregnancy Exploratory Analyses |
dolutegravir
|
exposure in pregnancy |
03/28/2019 |
| Acute Myocardial Infarction and Stroke Among Patients with Testosterone-Related Indications Exploratory Analyses |
testosterone
|
acute myocardial infarction (AMI) , stroke |
03/25/2019 |
| Brintellix and Brilinta Medication Errors due to Name Confusion Exploratory Analyses |
Brilinta, Brintellix
|
medication error |
03/24/2019 |
| Characteristics of Gout Patients and Use of Urate-Lowering Therapies Safety Analyses |
urate-lowering therapies
|
03/22/2019 | |
| SGLT-2 Inhibitor Use and Incidence of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus Exploratory Analyses |
canagliflozin, dapagliflozin, empagliflozin, sitagliptin, sodium-glucose cotransporter-2 (SGLT-2) inhibitor
|
diabetic ketoacidosis |
03/19/2019 |
| Stroke, Gastrointestinal Bleeding, and Intracranial Hemorrhage Following Apixaban or Warfarin Use in Patients with Non-Valvular Atrial Fibrillation: A Propensity Score Matched Analysis Safety Analyses |
apixaban
|
gastrointestinal (GI) bleed , intracranial hemorrhage , stroke |
02/14/2019 |
| Optimal Initial Length of Opioid Prescription Exploratory Analyses |
opioid analgesic
|
02/01/2019 | |
| Seizure Following Ranolazine Use Safety Analyses |
Ranexa, ranolazine
|
seizure |
01/03/2019 |
| Use of Multiple Sclerosis Drugs Among Pregnant Women Exploratory Analyses |
alemtuzumab, daclizumab, dalfampridine, dimethyl fumarate, fingolimod, glatiramer acetate, interferon beta-1A, interferon beta-1A/albumin, interferon beta-1B, mitoxantrone, natalizumab, peginterferon beta-1a, teriflunomide
|
pregnancy |
12/06/2018 |
| Pulmonary Arterial Hypertension and Interstitial Lung Disease Events Among Interleukin Inhibitor Users Exploratory Analyses |
interleukin-1/-6 inhibitor
|
interstitial lung disease , pulmonary arterial hypertension |
12/03/2018 |
| Duration of Use for Teriparatide Exploratory Analyses |
teriparatide
|
11/28/2018 | |
| Quantifying Prevalence and Mortality Associated with Neonatal Enteroviral Sepsis (NES) Using Inpatient Data in FDA’s Sentinel System Exploratory Analyses |
neonatal enteroviral sepsis (NES) |
11/27/2018 | |
| Counts and Proportions of New Users of Fentanyl Transdermal System with Evidence of Prior Opioid Tolerance Exploratory Analyses |
fentanyl transdermal system
|
11/06/2018 | |
| COPD, Asthma, and Respiratory Disease Effectiveness (CARE) For 21st Century Cures: Feasibility Assessments for Comparative Effectiveness Studies Exploratory Analyses |
asthma , chronic obstructive pulmonary disease |
11/06/2018 | |
| Phosphodiesterase Type 5 (PDE-5) Inhibitor Utilization Among Women Exploratory Analyses |
phosphodiesterase type 5 (PDE5) inhibitor
|
10/11/2018 | |
| Sofosbuvir and Amiodarone Use and Bradycardia or Pacemaker Insertion Exploratory Analyses |
amiodarone, sofosbuvir
|
bradycardia , pacemaker insertion |
08/29/2018 |
| Algorithms Evaluating Dabigatran Use and Acute Myocardial Infarction Compared with Warfarin Exploratory Analyses |
dabigatran, warfarin
|
acute myocardial infarction (AMI) |
08/23/2018 |
| Use of Dabigatran and Intracranial Hemorrhage, Gastrointestinal Hemorrhage, Ischemic Stroke, and Acute Myocardial Infarction Safety Analyses |
dabigatran
|
acute myocardial infarction (AMI) , gastrointestinal hemorrhage , intracranial hemorrhage , ischemic stroke |
08/17/2018 |
| New Pediatric Users of Leuprolide Acetate Exploratory Analyses |
leuprolide acetate
|
08/17/2018 | |
| Prevalence and Incidence of Progressive Multifocal Leukoencephalopathy (PML), Clostridium Difficile, and Cytomegalovirus (CMV) Diagnoses Exploratory Analyses |
clostridium difficile , cytomegalovirus (CMV) , progressive multifocal leukoencephalopathy (PML) |
06/04/2018 | |
| Incident Use of Selective Serotonin Reuptake Inhibitor Antidepressants Exploratory Analyses |
selective serotonin reuptake inhibitor (SSRI)
|
05/21/2018 | |
| Identifying Suicide Codes in the Sentinel Distributed Database (SDD) Exploratory Analyses |
suicide |
04/24/2018 | |
| Clostridium difficile Infection Following Use of Vancomycin, Fidaxomicin, or Metronidzaole Exploratory Analyses |
fidaxomicin, metronidazole, vancomycin
|
clostridium difficile |
04/03/2018 |
| Availability of International Normalized Ratio (INR) Laboratory Test Values and Test Procedures Among Warfarin Users Exploratory Analyses |
warfarin
|
04/02/2018 | |
| Warfarin Use Followed by International Normalized Ratio (INR) Lab Codes Exploratory Analyses |
warfarin
|
04/02/2018 | |
| Top Ten Causes of Death Exploratory Analyses |
03/29/2018 | ||
| Prevalent and Incident Use of Fingolimod Exploratory Analyses |
fingolimod
|
03/28/2018 | |
| Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone Users Exploratory Analyses |
carbidopa/levodopa, carbidopa/levodopa/entacapone (Stalevo), entacapone
|
03/27/2018 | |
| Prevalence and Incident Use of Promethazine Exploratory Analyses |
promethazine, promethazine/codeine, promethazine/phenylephrine/codeine
|
03/26/2018 | |
| Use of Clonazepam Exploratory Analyses |
clonazepam
|
03/26/2018 | |
| Diagnosis of Agranulocytosis Following New Use of Anti-epileptic Drugs, Clozapine, and Olanzapine Exploratory Analyses |
carbamazepine, clozapine, lamotrigine, levetiracetam, ofatumumab, olanzapine, topiramate
|
agranulocytosis |
03/21/2018 |
| Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate Exploratory Analyses |
alendronate sodium, alendronate sodium/vitamin d3, bandronate sodium, calcitonin salmon, calcitonin, salmon, synthetic, denosumab, ibandronate sodium, raloxifene HCL, risedronate sodium, risedronate sodium/calcium carbonate, teriparatide, zoledronic acid, zoledronic acid reclast, zoledronic acid/mannitol and water, zoledroniccid reclast, zoledroniccid zometa
|
03/19/2018 | |
| Counts and Prevalence of Linezolid and Vancomycin Exploratory Analyses |
linezolid, vancomycin
|
03/19/2018 | |
| Use of Atrial Fibrillation Drugs Exploratory Analyses |
dofetilide, sotalol HCL
|
03/16/2018 | |
| Incident Use of Hepatitis C Virus (HCV) Drugs Exploratory Analyses |
boceprevir, ledipasivir/sofosbuvir, simeprevir sodium, sofosbuvir, telaprevir
|
03/13/2018 | |
| Concomitancy and Indications for Idelalisib Use Exploratory Analyses |
bendamustine, bortezomib, chlorambucil, cyclophosphamide, doxorubicin, ibritumomab, ibrutinib, idelalisib, lenalidomide, obinutuzumab, ofatumumab, prednisone, rituximab, vincristine
|
03/12/2018 | |
| Prevalent and Incident Use of Generic Name Kinase Inhibitors Exploratory Analyses |
afatinib dimaleate, axitinib, bortezomib, cabozantinib s-malate, carfilzomib, ceritinib, crizotinib, dabrafenib mesylate, dasatinib, erlotinib HCL, everolimus, gefitinib, ibrutinib, idelalisib, imatinib mesylate, lapatinib ditosylate, nilotinib HCL, pazopanib HCL, ponatinib HCL, regorafenib, ruxolitinib phosphate, sorafenib tosylate, sunitinib malate, trametinib dimethyl sulfoxide, vandetanib, vemurafenib
|
03/08/2018 | |
| Incident Use of Rivaroxaban Exploratory Analyses |
rivaroxaban
|
03/07/2018 | |
| Selected Medications and Death, with Linkage of Mini-Sentinel Distributed Database with NDI+ Exploratory Analyses |
amiodarone, amitriptyline, amoxapine, amoxicillin, amoxicillin with clavulanate, azithromycin, cephalexin, ciprofloxacin, citalopram, clarithromycin, clindamycin, clomipramine, desipramine, desvenlafaxine, dofetilide, doxepin, dronedarone, duloxetine, erythromycin, escitalopram, flecainide, fluoxetine, fluvoxamine, gemifloxacin, imipramine, levofloxacin, levomilnacipran, maprotiline, mirtazapine, moxifloxacin, nefazodone, norfloxacin, nortriptyline, ofloxacin, paroxetine, penicillin V, propafenone, protriptyline, sertraline, sotalol, telithromycin, trazodone, trimethoprim-sulfamethoxazole, trimipramine, venlafaxine, vilazodone, vortioxetine
|
sudden cardiac death |
03/06/2018 |
| Combined Oral Contraceptives Containing Ethinyl Estradiol and Levonorgestrel and Venous Thromboembolism Safety Analyses |
combined oral contraceptive (COC)
|
venous thromboembolism (VTE) |
03/03/2018 |
| Venous Thromboembolism Following Continuous or Extended Cycle Contraceptive Use: A Propensity Score Matched Analysis Safety Analyses |
combined oral contraceptive (COC)
|
venous thromboembolism (VTE) |
03/03/2018 |
| Counts, Prevalence, and Incidence of Intravenous (IV) Iron Products Exploratory Analyses |
ferumoxytol, iron dextran complex, iron sucrose complex, sodium ferric gluconate complex
|
03/02/2018 | |
| Exposure to Intravenous (IV) Iron Procedures and Anaphylaxis and Epinephrine Events Safety Analyses |
intravenous (IV) iron
|
anaphylaxis , epinephrine event |
03/02/2018 |
| Rhabdomyolysis and/or Creatine Kinase Laboratory Results Following New Use of Statins or Angiotensin-Converting Enzyme Inhibitors Exploratory Analyses |
angiotensin-converting enzyme (ACE) inhibitor, statin
|
creatine kinase laboratory result , rhabdomyolysis |
03/01/2018 |
| Length of Follow-up Time for New Users of Immunosuppressive Drugs Exploratory Analyses |
adalimumab, alemtuzumab, certolizumab, dalfampridine, dimethyl fumarate, etanercept, fingolimod, glatiramer acetate, golimumab, infliximab, interferon beta-1A, interferon beta-1B, mitoxantrone, natalizumab, pegylated interferon beta-1A, teriflunomide, ustekinumab
|
02/27/2018 | |
| Use of Tyrosine Kinase Inhibitors (TKIs) Exploratory Analyses |
axitinib, pazopanib, sorafenib, sunitinib, tyrosine kinase inhibitor
|
02/27/2018 | |
| Prevalent and Incident Dispensings of Ranolazine Safety Analyses |
ranolazine
|
02/26/2018 | |
| Boceprevir, Ledipasivir/Sofosbuvir, Simeprevir Sodium, Sofosbuvir, and Telaprevir Use Exploratory Analyses |
boceprevir, ledipasivir/sofosbuvir, simeprevir sodium, sofosbuvir, telaprevir
|
hepatitis C |
02/05/2018 |
| Concomitant Use of Opioid Analgesics and Cytochrome P450 (CYP) Inhibitors and Inducers Safety Analyses |
CYP inducer, CYP inhibitor, oxycodone, oxymorphone
|
02/01/2018 | |
| Prevalent and Incident Use of SGLT2 Inhibitors Exploratory Analyses |
canagliflozin, canagliflozin/metformin HCl, dapagliflozin propanediol, dapagliflozin/metformin HCl, empagliflozin, empagliflozin/linagliptin
|
02/01/2018 | |
| Metabolic Effects of Second Generation Antipsychotics in Youth, Subprojects 1, 2, and 3 Safety Analyses |
aripiprazole, olanzapine, quetiapine, risperidone, second generation antipsychotic (SGA)
|
metabolic syndrome , type 2 diabetes mellitus , weight gain |
01/31/2018 |
| PROMPT: Rivaroxaban Surveillance Safety Analyses |
rivaroxaban, warfarin
|
gastrointestinal (GI) bleed , intracranial hemorrhage , ischemic stroke |
01/31/2018 |
| Antiepileptic Drug (AED) Injection Procedure Codes Exploratory Analyses |
anti-epileptic drug (AED)
|
01/31/2018 | |
| Counts of Commonly Used Angiostensin-Converting Enzyme (ACE) Inhibitors and Beta Blockers Exploratory Analyses |
angiotensin-converting enzyme (ACE) inhibitor, beta blocker
|
01/29/2018 | |
| Drug and Medical Enrollment Counts Exploratory Analyses |
01/29/2018 | ||
| A Protocol for Assessment of Dabigatran and Selected Safety Outcomes Safety Analyses |
dabigatran, warfarin
|
intracranial hemorrhage , ischemic stroke , major extracranial hemorrhage |
01/26/2018 |
| Use of Tumor Necrosis Factor (TNF) Blocker Drugs Exploratory Analyses |
tumor necrosis factor (TNF) blocker
|
01/26/2018 | |
| Characterization of Pediatric Medical Conditions: Respiratory Syncytial Virus (RSV) Associated Illness Exploratory Analyses |
respiratory syncytial virus (RSV) |
01/24/2018 | |
| Molecularly Targeted Anti-Cancer Therapies Exploratory Analyses |
axitinib, bicalutamide, crizoatinib, dasatinib, erlotinib HCL, everolimus, gefitinib, imatinib mesylate, lapatinib ditosylate, nilotinib HCL, pazopanib HCL, ruxolitinib phosphate, sorafenib tosylate, sunitinib malate, tamoxifen citrate, vandetanib, vemurafenib, vismodegib
|
01/24/2018 | |
| Stroke Diagnosis Codes Exploratory Analyses |
stroke |
01/18/2018 | |
| Length of Enrollment in Pediatric Population Exploratory Analyses |
01/17/2018 | ||
| Prevalent and Incident Use of Isotretinoin Exploratory Analyses |
isotretinoin
|
01/16/2018 | |
| Occurrence of Selected Generic Drugs 13 Exploratory Analyses |
amlodipine besylate, efalizumab, ibandronate sodium, lamotrigine, leflunomide, maraviroc, metoclopramide HCL, nitrofurantoin, nitrofurantoin macrocrystal, nitrofurantoin monohyd/m-crystal, propylthiouracil, quinine, quinine sulfate, ramipril, rosiglitazone maleate, sibutramine HCL m-hydrate, tadalafil, varenicline tartrate
|
01/11/2018 | |
| Clostridium Difficile Prevalence and Vancomycin, Fidaxomicin, and Tocilizumab Use Exploratory Analyses |
fidaxomicin, tocilizumab, vancomycin
|
clostridium difficile |
01/08/2018 |
| Use of Dronedarone HCL Exploratory Analyses |
dronedarone HCL
|
01/08/2018 | |
| Incident and Prevalent Dispensings of Mirabegron Exploratory Analyses |
mirabegron
|
01/01/2018 | |
| Use of Ospemifene, Boceprevir, and Telaprevir Exploratory Analyses |
boceprevir, ospemifene, telaprevir
|
12/29/2017 | |
| Prevalent and Incident Use of Testosterone Products Exploratory Analyses |
testosterone
|
12/21/2017 | |
| Top 100 Procedures and Diagnoses 30 Days Surrounding Incident Warfarin Use Exploratory Analyses |
warfarin
|
12/21/2017 | |
| Anti-Tumor Necrosis Factor (TNF) Utilization Among Pregnant Women Exploratory Analyses |
adalimumab, certolizumab, etanercept, golimumab, infliximab, tumor necrosis factor (TNF) alpha inhibitor
|
12/19/2017 | |
| Prevalent and Incident Use of Romiplostim Exploratory Analyses |
romiplostim
|
12/18/2017 | |
| Suicide Diagnoses Exploratory Analyses |
suicide |
12/15/2017 | |
| Incident and Prevalent Use of Generic Drugs for Overactive Bladder Exploratory Analyses |
darifenacin hydrobromide, fesoterodine fumarate, oxybutynin chloride, solifenacin succinate, tolterodine tartrate, trospium chloride
|
12/11/2017 | |
| Use of Cancer Drugs Exploratory Analyses |
crizoatinib, erlotinib HCL, ipilimumab, nivolumab, pembrolizumab
|
12/08/2017 | |
| Antipsychotic Use and Dementia Diagnoses Exploratory Analyses |
antipsychotic
|
dementia |
12/07/2017 |
| Genetic Testing Procedures Exploratory Analyses |
12/05/2017 | ||
| Atrial Fibrillation Prevalence Exploratory Analyses |
atrial fibrillation , atrial flutter |
12/04/2017 | |
| Mycophenolate Dispensings and Procedures Exploratory Analyses |
mycophenolate mofetil, mycophenolate mofetil HCL, mycophenolate sodium
|
12/01/2017 | |
| Mycophenolate Dispensings and Procedures (by Quarter) Exploratory Analyses |
mycophenolate mofetil, mycophenolate mofetil HCL, mycophenolate sodium
|
12/01/2017 | |
| Niacin and Fenofibrate Use and Outcomes with Propensity Score Matching Safety Analyses |
extended-release (ER) niacin, fenofibrate
|
gastrointestinal (GI) bleed , intracranial hemorrhage , ischemic stroke |
11/05/2017 |
| Stroke Following Typical or Atypical Antipsychotic Use in Non-Elderly Patients: A Propensity Score Matched Analysis Exploratory Analyses |
antipsychotic
|
stroke |
11/02/2017 |
| Stroke Following Atypical Antipsychotic or Z-Hypnotic Use in Patients with Prior Use of Selective Serotonin Reuptake Inhibitors (SSRIs): A Propensity Score Matched Analysis Exploratory Analyses |
aripiprazole, fluoxetine, olanzapine, quetiapine, risperidone
|
stroke |
11/01/2017 |
| Antipsychotics and Stroke Exploratory Analyses |
aripiprazole, atypical antipsychotic, haloperidol, olanzapine, olanzapine/fluoxetine, quetiapine, risperidone, selective serotonin reuptake inhibitor (SSRI), typical antipsychotic
|
intracranial hemorrhage , ischemic stroke |
11/01/2017 |
| Sodium/Glucose Cotransporter (SGLT2) Inhibitors- Type 1 and Type 2 Diabetes Cohort Identification Exploratory Analyses |
dipeptidyl peptidase-4 (DPP-4) inhibitor, sodium-glucose cotransporter-2 (SGLT-2) inhibitor, sulfonylurea
|
diabetes , type 1 diabetes mellitus , type 2 diabetes mellitus |
10/30/2017 |
| Niacin and Niacin Combination Products, Fenofibrates, and Omega-3 Products Exploratory Analyses |
fenofibrate, niacin, niacin/lovastatin, niacin/simvastatin, omega-3 product
|
10/12/2017 | |
| Alosetron Use Exploratory Analyses |
alosetron HCL
|
10/11/2017 | |
| Mirabegron Use Exploratory Analyses |
mirabegron
|
10/11/2017 | |
| Pegylated Products Use Exploratory Analyses |
certolizumab pegol, methoxy peg-epoetin beta, pegademase bovine, peginterferon beta-1a, pegloticase, pegvisomant
|
10/06/2017 | |
| Pegylated Products Follow-Up Request Exploratory Analyses |
10/06/2017 | ||
| New Molecular Entities Exploratory Analyses |
abiraterone acetate, aclidinium bromide, ado-trastuzumab emtansine, afatinib dimaleate, albiglutide, alcaftadine, alectinib HCL, alglucosidase alfa, alirocumab, alogliptin benzoate, apixaban, apremilast, aripiprazole, aripiprazole lauroxil, asfotase alfa, asparaginase, avanafil, axitinib, azilsartan medoxomil, bazedoxifene, bedaquiline fumarate, belatacept, belimumab, belinostat, blinatumomab, boceprevir, bosutinib, brexpiprazole, cabazitaxel, cabozantinib, canagliflozin, cangrelor tetrasodium, carfilzomib, carglumic acid, cariprazine HCL, ceftaroline fosamil acetate, ceftazidime/avibactam, ceftolozane, ceritinib, cholic acid, clobazam, cobicistat, cobimetinib fumarate, collagenase clostridium histolyticum, crofelemer, dabigatran etexilate mesylate, dabrafenib mesylate, daclatasvir dihydrochloride, dalbavancin HCL, dalfampridine, dapagliflozin propanediol, daratumumab, deferiprone, denosumab, deoxycholic acid, dimethyl fumarate, dinutuximab, dolutegravir sodium, droxidopa, dulaglutide, edoxaban tosylate, efinaconazole, eliglustat tartrate, elosulfase alfa, elotuzumab, eluxadoline, elvitegravir, elvitegravir/cobicistat/emtricitabine/tenofovir, empagliflozin, enzalutamide, eribulin mesylate, eslicarbazepine acetate, estradiol valerate/dienogest, estrogen, evolocumab, ezogabine, fidaxomicin, fingolimod HCL, flibanserin, florbetapir f-18, fluconazole, flutemetamol f-18, gabapentin enacarbil, gadobutrol, gadoterate meglumine, glucarpidase, ibrutinib, icatibant acetate, idarucizumab, idelalisib, incobotulinumtoxina, indacterol maleate, ingenol mebutate, insulin degludec, ioflupane i-123, ipilimumab, isavuconazonium sulfate, ivabradine HCL, ivacaftor, ixazomib citrate, ledipasvir, lenvatinib mesylate, linaclotide, linagliptin, liraglutide, lomitapide mesylate, lorcaserin HCl, lucinactant, luliconazole, lumacaftor/ivacaftor, lurasidone HCL, macitentan, mepolizumab, metreleptin, miltefosine, mipomersen sodium, naloxegol oxalate, necitumumab, netupitant, nintedanib esylate, nivolumab, obinutuzumab, ocriplasmin, olaparib, olodaterol HCL, omacetaxine mepesuccinate, ombitasvir, oritavancin diphosphate, osimertinib mesylate, ospemifene, palbociclib, palonosetron HCL, panobinostat lactate, parathyroid hormone, paritaprevir, pasireotide diaspartate, patiromer calcium sorbitex, peginterferon beta-1a, pegloticase, pembrolizumab, peramivir, pirfenidone, pitavastatin, polidocanol, pomalidomide, radium-223 dichloride, ramucirumab, rilpivirine HCL, riociguat, rivaroxaban, roflumilast, rolapitant HCL, ruxolitinib phosphate, sacubitril/valsartan, sebelipase alfa, secukinumab, selexipag, siltuximab, simeprevir sodium, sofosbuvir, sonidegib phosphate, spinosad, sugammadex sodium, sulfur hexafluoride microsphere, suvorexant, tasimelteon, tazobactam, tedizolid phosphate, teduglutide, telaprevir, tenofovir disoproxil fumarate, teriflunomide, tesamorelin acetate, ticagrelor, tocilizumab, tofacitinib citrate, trabectedin, trametinib dimethyl sulfoxide, trifluridine/tipiracil HCL, ulipristal acetate, umeclidinium, uridine, vandetanib, vedolizumab, velaglucerase alfa, vemurafenib, vilanterol, vilazodone HCL, vismodegib, vorapaxar sulfate, vortioxetine hydrobromide, ziv-aflibercept
|
10/04/2017 | |
| Indications of Use Among Oral Antifungal Drug Users Exploratory Analyses |
fluconazole, griseofulvin, itraconazole, ketoconazole, terbinafine
|
09/01/2017 | |
| Actemra (Tocilizumab) Utilization Among Pregnant Women Exploratory Analyses |
Actemra, tocilizumab
|
juvenile rheumatoid arthritis , rheumatoid arthritis |
07/17/2017 |
| Anti-epileptic Drugs and Angioedema Exploratory Analyses |
lacosamide, lamotrigine, levetiracetam, oxcarbazepine, phenytoin
|
angioedema |
07/17/2017 |
| Drug Use Following Genetic Testing Among Patients with Cancer Exploratory Analyses |
afatinib dimaleate, BCR-ABL, bosutinib, BRAF, BRCA, cetuximab, cobimetinib fumarate, dabrafenib mesylate, dasatinib, erlotinib HCL, estimated glomerular filtration rate (eGFR), gefitinib, imatinib mesylate, KRAS, nilotinib HCL, olaparib, osimertinib mesylate, panitumumab, ponatinib HCL, trametinib dimethyl sulfoxide, vemurafenib
|
cancer |
05/10/2017 |
| Multiple Births and Preterm Deliveries Exploratory Analyses |
preterm delivery |
05/09/2017 | |
| Influenza Antiviral Drug Use 2010-2015 Exploratory Analyses |
oseltamivir, zanamivir
|
05/02/2017 | |
| Prevalent Dispensings of Ticagrelor (Brilinta) and Vortioxetine Hydrobromide (Brintellix) Exploratory Analyses |
Brilinta, Brintellix, ticagrelor, vortioxetine hydrobromide
|
04/23/2017 | |
| Attention Deficit Hyperactivity Disorder (ADHD) Medications and Heart Failure Exploratory Analyses |
amphetamine, methylphenidate, Strattera
|
heart failure or cardiomyopathy |
10/25/2016 |
| PROMPT: Mirabegron Surveillance Exploratory Analyses |
mirabegron, oxybutynin
|
acute myocardial infarction (AMI) , stroke |
09/20/2016 |
| Dronedarone and Electrocardiograms Exploratory Analyses |
dronedarone
|
electrocardiogram |
08/15/2016 |
| Parenteral Iron and Anaphylactoid Reactions Safety Analyses |
parenteral iron (IV iron)
|
anaphylactoid reaction |
07/22/2016 |
| Dabigatran and Warfarin Use Among Members with Atrial Fibrillation and Other Pre-Existing Conditions Exploratory Analyses |
dabigatran, warfarin
|
07/21/2016 | |
| MRI and GBCA Procedures Exploratory Analyses |
07/21/2016 | ||
| Hysterectomy Procedures Among Females Exploratory Analyses |
hysterectomy , morcellation , uterine fibroid |
07/21/2016 | |
| Most Frequent Generic Dispensings Among Members Aged 65+ Exploratory Analyses |
07/20/2016 | ||
| Incident Testosterone Indication Diagnoses and Testosterone Use Exploratory Analyses |
testosterone
|
07/06/2016 | |
| Hypogonadism and Testosterone Use Exploratory Analyses |
testosterone
|
hypogonadism |
07/06/2016 |
| Incident Testosterone Use Exploratory Analyses |
testosterone
|
07/06/2016 | |
| Immunoglobulin Products and Hemolysis Exploratory Analyses |
immunoglobulin (Ig)
|
hemolysis |
07/06/2016 |
| New Use of Statins and Rhabdomyolysis Exploratory Analyses |
atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, simvastatin, statin
|
rhabdomyolysis |
06/30/2016 |
| Epidural Steroid Use Exploratory Analyses |
epidural steroid
|
06/30/2016 | |
| Serum Creatinine Procedures and Labs Exploratory Analyses |
06/30/2016 | ||
| Isotretinoin and Long-term Antibiotic Use and Multiple Sclerosis Exploratory Analyses |
abacavir, doxycycline, erythromycin, isotretinoin, lamivudine, long-term antibiotic, minocycline, zidovudine
|
multiple sclerosis |
06/30/2016 |
| Omalizumab or Montelukast Use Among Individuals with Asthma and Acute Myocardial Infarction, Stroke, Intracranial Hemorrhage, or Pulmonary Embolism Exploratory Analyses |
omalizumab
|
acute myocardial infarction (AMI) , intracranial hemorrhage , stroke |
06/21/2016 |
| Laparoscopic Hysterectomy With and Without Robotic Assistance and Adverse Outcomes Exploratory Analyses |
laparoscopic hysterectomy
|
intraoperative complication , medical complication , surgical site complication |
06/21/2016 |
| New Use of Dabigatran or Warfarin and Gastrointestinal Hemorrhage or Intracerebral Hemorrhage Events Exploratory Analyses |
dabigatran, warfarin
|
gastrointestinal hemorrhage , intracerebral hemorrhage (ICH) |
06/21/2016 |
| New Use of Anti-Epileptic Drugs and Agranulocytosis Exploratory Analyses |
anti-epileptic drug (AED), carbamazepine, lamotrigine, levetiracetam, topiramate
|
absolute neutrophil count (ANC) , agranulocytosis |
06/21/2016 |
| Incident Use of Testosterone Products Among All Members and Members with Pre-Existing Testosterone Use Exploratory Analyses |
Androgel, Axiron, Fortesta, intramuscular testosterone, methyltestosterone, Striant, Testim, testosterone, testosterone cypionate, testosterone enanthate, testosterone pellet, testosterone propionate, testosterone suspension, transdermal testosterone
|
06/03/2016 | |
| Concomitant Use of Niacin and Statins and Concomitant Use of Fenofibrates and Statins Exploratory Analyses |
fenofibrate, niacin, statin
|
06/03/2016 | |
| IVIg Product Use and Hemolysis Events Exploratory Analyses |
flebogamma, Gammagard, Gammaplex, Gamunex, intravenous immunoglobulin (IVIg), Octagam, Privigen
|
06/03/2016 | |
| Anticoagulant Use Among Members with Atrial Fibrillation and Various Pre-Existing Exlusions Exploratory Analyses |
anticoagulant, dabigatran, warfarin
|
05/27/2016 | |
| Anticoagulant Use Among Members with Pre-Existing Atrial Fibrillation and Various Pre-Existing Exclusions Exploratory Analyses |
anticoagulant, dabigatran, warfarin
|
05/25/2016 | |
| Antidepressant Use and Bleeding Events Exploratory Analyses |
antidepressant, selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic
|
bleeding event , gastrointestinal hemorrhage , intracerebral hemorrhage (ICH) |
05/20/2016 |
| Dabigatran Uptake and Persistence Exploratory Analyses |
dabigatran
|
05/20/2016 | |
| Incident Antipsychotic Use Exploratory Analyses |
antipsychotic, aripiprazole, asenapine, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone
|
05/20/2016 | |
| Indications of Intravenous Immunoglobulin Use Exploratory Analyses |
intravenous immunoglobulin (IVIg)
|
05/20/2016 | |
| Anticoagulants and Bleeding Events Exploratory Analyses |
anticoagulant, dabigatran, warfarin
|
bleeding event |
05/20/2016 |
| Anticoagulant Use Among Patients with Atrial Fibrillation Exploratory Analyses |
anticoagulant, dabigatran, oral formulation of apixaban, rivaroxaban, warfarin
|
01/31/2016 | |
| Drug Use Among Pregnant Women with Live Births Exploratory Analyses |
angiotensin-converting enzyme (ACE) inhibitor, anticonvulsant, dabigatran, lisinopril, methotrexate, mycophenolate mofetil, paroxetine, ribavirin, selective serotonin reuptake inhibitor (SSRI), simvastatin, sodium valproate, statin, valproic acid, warfarin
|
01/29/2016 | |
| Anti-Diabetes Drugs and Acute Myocardial Infarction, Hospitalized Heart Failure Safety Analyses |
anti-diabetic agent (ADA), dipeptidyl peptidase-4 (DPP-4) inhibitor, glimepiride, glipizide, glyburide, hypoglycemic drug, long-acting insulin, pioglitazone, saxagliptin, sitagliptin, sulfonylurea, thiazolidinedione
|
acute myocardial infarction (AMI) , heart failure |
01/26/2016 |
| Select Bisphosphonates and Select Outcomes of Interest Exploratory Analyses |
biphosphonate
|
esophageal cancer , fracture , hip fracture , non-vertebral fracture , osteonecrosis of the jaw |
03/14/2015 |
| Anaphylaxis Events Following Incident Vaccine Exposure Among Members with a Pre-Existing Condition of Milk Allergy Exploratory Analyses |
diphtheria, tetanus, acellular pertussis (DTaP) vaccine, diphtheria, tetanus, acellular pertussis (DTaP)-haemophilus influenzae type B (HIB) vaccine, diphtheria, tetanus, acellular pertussis (DTaP)-haemophilus influenzae type B (HIB)-inactivated polio vaccine (IPV), diphtheria, tetanus, acellular pertussis (DTaP)-hepatitis B (Hep B)-inactivated polio vaccine (IPV), diphtheria, tetanus, acellular pertussis (DTaP)-inactivated polio vaccine (IPV), tetanus, diphtheria, pertussis (Tdap) vaccine
|
anaphylactic shock |
03/03/2015 |
| Gastrointestinal Disorders Exploratory Analyses |
entercolitis , gastrointestinal disorder , ileocolitis , procitis , proctosigmoiditis , pseudopolyposis , regional enteritis , ulcerative colitis |
02/25/2015 | |
| Injection Omalizumab Procedure Codes Exploratory Analyses |
omalizumab
|
02/25/2015 | |
| Omalizumab Use Exploratory Analyses |
omalizumab
|
02/25/2015 | |
| Prevalent and Incident Use of Pramipexole Exploratory Analyses |
pramipexole
|
02/25/2015 | |
| Hypoglycemic Events Following Use of Anti-Diabetic Agents (ADAs) Exploratory Analyses |
anti-diabetic agent (ADA), chlorpropamide, glimepiride, glipizide, glipizide/metformin, glyburide, glyburide/metformin, insulin, metformin, pioglitazone, pioglitazone/metformin, rosiglitazone maleate, rosiglitazone/metformin, tolazamide
|
hypoglycemia |
02/25/2015 |
| Omalizumab and Montelukast Use Exploratory Analyses |
montelukast, omalizumab
|
02/25/2015 | |
| Progressive Multifocal Leukoencephalapathy Exploratory Analyses |
progressive multifocal leukoencephalopathy (PML) |
02/24/2015 | |
| Methotrexate and Tofacitinib Use Exploratory Analyses |
methotrexate, methotrexate sodium, methotrexate sodium, preservative free, tofacitinib citrate
|
11/24/2014 | |
| Incident and Prevalent Use of Alvimopan, Naltrexone, and Methylnaltrexone Exploratory Analyses |
alvimopan, methylnaltrexone bromide, morphine sulfate/naltrexone, naltrexone, naltrexone HCL, naltrexone microsphere
|
11/23/2014 | |
| Procedure Codes Related to Memory Gel Breast Implants Exploratory Analyses |
breast implant
|
11/10/2014 | |
| Opioid Medication Use Exploratory Analyses |
Buprenex, Butrans, generic injectable buprenorphine, generic oral buprenorphine, generic powder buprenorphine, opioid, Suboxone, Subutex
|
11/09/2014 | |
| Buprenorphine Product Use Exploratory Analyses |
buprenorphine
|
11/09/2014 | |
| CPAX Aneurysm Procedure Codes Exploratory Analyses |
CPAX aneurysm , emboli detection , intravenous microbubble injection , surgery of intracranial aneurysm , transcranial doppler study |
10/21/2014 | |
| Lap-band Diagnosis Codes Exploratory Analyses |
gastric lap band
|
bariatric surgery , gastric band procedure |
10/20/2014 |
| Activa Tremor Control Procedures Exploratory Analyses |
Activa Tremor Control |
10/16/2014 | |
| Ascension Metacarpophalangeal Diagnoses Exploratory Analyses |
Ascension metacarpophalangeal (MCP) , arthritis , diffuse disease of connective tissue , osteoarthritis , sprain and strain of metacarpophalangeal of hand , traumatic arthropathy |
10/16/2014 | |
| Ascension Metacarpophalangeal Procedures Exploratory Analyses |
arthroplasty metacarpophalangeal interphalangeal joint , arthrotomy for removal of prosthesis , division of joint |
10/16/2014 | |
| CPAX Aneurysm Diagnoses Exploratory Analyses |
CPAX aneurysm , aneurysm , arthropod-borne hemorrhagic fever , cerebral aneurysm nonruptured , intracerebral hemorrhage (ICH) , mosquito-borne viral encephalitis , subarcahnoid hemorrhage |
10/16/2014 | |
| Activa Tremor Control Diagnoses Exploratory Analyses |
neuropacemaker
|
Activa Tremor Control , essential tremor , other specified forms of tremor , paralysis agitans |
10/15/2014 |
| Dialysis HCPCS Procedure Codes Exploratory Analyses |
dialysis , end-stage renal disease (ESRD) , kidney failure |
10/14/2014 | |
| Dialysis ICD9 Diagnosis Codes Exploratory Analyses |
dialysis , end-stage renal disease (ESRD) , kidney failure |
10/13/2014 | |
| Dialysis ICD9 Procedure Codes Exploratory Analyses |
dialysis , end-stage renal disease (ESRD) , kidney failure |
10/13/2014 | |
| Anti-Infective Agents Use 2 Exploratory Analyses |
anti-infective agent
|
09/23/2014 | |
| Cardiovascular Therapy Agent Use 2 Exploratory Analyses |
acebutolol HCL, cardiovascular therapy agent
|
09/23/2014 | |
| Gastrointestinal Therapy Agents Use 2 Exploratory Analyses |
gastrointestinal therapy agent
|
09/23/2014 | |
| Antiepileptic Drugs (AEDs) and Kidney Stones 2 Exploratory Analyses |
anti-epileptic drug (AED), carbamazepine, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, phenytoin, topiramate, valproic acid, zonisamide
|
kidney stone |
09/23/2014 |
| Infectious Disease Diagnoses Exploratory Analyses |
Chagas disease , anthrax , ascariasis , hepatitis , hepatitis C , hookworm , influenza , leishmaniasis , malaria , methicillin-resistant Staphylococcus aureus (MRSA) , plague , schistosomiasis , trichuriasis , tuberculosis (TB) , tularemia |
09/23/2014 | |
| Occurrence of Selected Generic Drugs 12 Exploratory Analyses |
09/22/2014 | ||
| Analgesic Use 3 Exploratory Analyses |
analgesic
|
08/12/2014 | |
| Diabetes Diagnoses and Occurrence of Laboratory Results Exploratory Analyses |
06/12/2014 | ||
| Anti-D, Dexamethasone, Prednisone, Romiplostim and Hemolysis Exploratory Analyses |
anti-D, dexamethasone, prednisone, romiplostim
|
hemolysis |
06/10/2014 |
| Immune Globulin Use Exploratory Analyses |
immune globulin, gamma (IgG), immune globulin, gamma (IgG)/maltose, immune globulin, gamma caprylate (IgG)
|
06/05/2014 | |
| Injection Gammagard Use Exploratory Analyses |
Gammagard
|
06/04/2014 | |
| Hemorrhagic Disorder Diagnoses Exploratory Analyses |
acquired hemophilia , hemorrhagic disorder |
06/04/2014 | |
| Occurrence of Kidney Stones Exploratory Analyses |
anti-diabetic agent (ADA)
|
kidney stone |
02/25/2014 |
| Hemodialysis Procedures Exploratory Analyses |
hemodialysis |
01/12/2014 | |
| Enoxaparin Sodium Use Exploratory Analyses |
enoxaparin sodium
|
01/12/2014 | |
| Injection Enoxaparin Sodium Use Exploratory Analyses |
enoxaparin sodium
|
01/12/2014 | |
| Acute Kidney Failure Diagnoses Exploratory Analyses |
acute kidney failure |
01/11/2014 | |
| Occurrence of Selected Dental HCPCS Codes Exploratory Analyses |
01/11/2014 | ||
| Nursing Home Facility HCPCS Codes Exploratory Analyses |
01/10/2014 | ||
| Prevalent and Incident Use of Acetazolamide Exploratory Analyses |
acetazolamide
|
01/09/2014 | |
| Long Acting Beta2-Agonists (LABA) Policies and Drug Utilization Patterns Exploratory Analyses |
long-acting beta2 agonist (LABA)
|
change in drug utilization patterns |
01/08/2014 |
| Prevalent and Incident Use of Quinine Sulfate Exploratory Analyses |
quinine sulfate
|
01/08/2014 | |
| Quinine Sulfate, Diltiazem and Selected Thrombotic Events Exploratory Analyses |
diltiazem, quinine sulfate
|
hemolytic-uremic syndrome , immune thrombocytopenic purpura , other secondary thrombocytopenia , thrombotic microangiopathy , unspecified thrombocytopenia |
01/08/2014 |
| Anti-Seizure Medication Use Exploratory Analyses |
carbamazepine, ethosuxamide, felbamate, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, phentermine HCl, phentermine resin, phenytoin, phenytoin sodium, phenytoin sodium extended, pregabalin, tiagabine HCL, topiramate, valproic acid, zonisamide
|
01/08/2014 | |
| Occurrence of Selected Generic Drugs 11 Exploratory Analyses |
benzyl alcohol, boceprevir, dabigatran etexilate mesylate, eltrombopag olamine, febuxostat, pitavastatin calcium, Pradaxa, rivaroxaban, telaprevir, vigabatrin
|
01/08/2014 | |
| Multiple Sclerosis Medication Use Exploratory Analyses |
fingolimod HCL, glatiramer acetate, interferon beta-1A, interferon beta-1A/albumin, interferon beta-1B, mitoxantrone HCL, natalizumab
|
01/08/2014 | |
| Multiple Sclerosis Medication Injections Exploratory Analyses |
injection glatiramer acetate, injection interferon beta-1A, injection interferon beta-1A, injection interferon beta-1B, injection mitoxantrone HCL, injection natalizumab
|
01/08/2014 | |
| Antiepileptic Drugs (AEDs) and Kidney Stones Exploratory Analyses |
anti-epileptic drug (AED), carbamazepine, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, phenytoin, topiramate, zonisamide
|
kidney stone |
01/07/2014 |
| Chronic Kidney Disease Diagnoses Exploratory Analyses |
chronic kidney disease (CKD) |
12/29/2013 | |
| Nursing Home HCPCS Codes Exploratory Analyses |
12/29/2013 | ||
| Oral Antifungal Use Exploratory Analyses |
fluconazole, itraconazole, ketoconazole, posaconazole, terbinafine, voriconazole
|
11/20/2013 | |
| Occurrence of Selected Generic Drugs 10 Exploratory Analyses |
allopurinol, diclofenac, isoniazid, lapatinib, telithromycin, ticlopidine
|
11/20/2013 | |
| Antiepileptic Drug Use Exploratory Analyses |
acetazolamide, carbamazepine, clobazam, clonazepam, diazepam, ethosuxamide, ezogabine, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, lorazepam, oxcarbazepine, phenobarbital, phenytoin, pregabalin, primidone, rufinamide, tiagabine, topiramate, valproic acid, vigabatrin, zonisamide
|
11/20/2013 | |
| HIV and HBV Infection Diagnoses Exploratory Analyses |
hepatitis B virus (HBV) , human immunodeficiency virus (HIV) |
10/07/2013 | |
| Bupropion HCL Sustained Release HCPCS Codes Exploratory Analyses |
bupropion HCL sustained release tablet
|
10/07/2013 | |
| Propylthiouracil and Methimazole Use 2 Exploratory Analyses |
methimazole, propylthiouracil
|
10/07/2013 | |
| Unspecified Anterior Pituitary Hyperfunction and Hypertrophy of the Breast Diagnoses Exploratory Analyses |
anterior pituitary hyperfunction , hypertrophy |
10/07/2013 | |
| Occurrence of Selected Generic Drugs 9 Exploratory Analyses |
ezetimibe/simvastatin, lisinopril, lisinopril/dietary sup. Cmb10, lisinopril/hydrochlorothiazide, methotrexate, methotrexate sodium, mycophenolate mofetil, mycophenolate sodium, niacin/simvastatin, paroxetine HCL, paroxetine mesylate, ribavirin, ribavirin/interferon alfa-2B, simvastatin, valproic acid, warfarin sodium
|
10/06/2013 | |
| Analgesic Use 2 Exploratory Analyses |
acetaminophen with codeine, aspirin/codeine phosphate, codeine phosphate, codeine sulfate, fentanyl citrate, methadone HCL, morphine sulfate, oxycodone HCL, oxymorphone HCL, sulindac, tramadol HCL
|
09/13/2013 | |
| Anti-Infective Agents Use Exploratory Analyses |
acyclovir, acyclovir sodium, atovaquone, doxycycline calcium, doxycycline hyclate, nitazoxanide, norfloxacin, telithromycin, tenofovir disoproxil fumarate
|
09/13/2013 | |
| Cardiovascular Therapy Agents Use Exploratory Analyses |
acebutolol HCL, aliskiren hemifumarate, ambrisentan, amlodipine besylate, atenolol, betaxolol HCL, bosentan, captopril, carvedilol, conivaptan HCL, diltiazem HCL, eprosartan mesylate, indapamide, labetalol HCL, lisinopril, metoprolol succinate, metoprolol tartrate, metoprolol/hydrochlorothiazide, nadolol, nimodipine, perindopril erbumine, propafenone HCL, trandolapril, triamterene
|
09/13/2013 | |
| Gastrointestinal Therapy Agents Use Exploratory Analyses |
aprepitant, cimetidine, dexlansoprazole, dicyclomine HCL, fosaprepitant dimeglumine, lubiprostone, mesalamine, nizatidine, sucralfate
|
09/12/2013 | |
| Occurrence of Selected Generic Drugs 8 Exploratory Analyses |
alosetron HCL, alvimopan, ambrisentan, bosentan, buprenorphine HCL, bupropion HCL, isotretinoin, lenalidomide, metoclopramide HCL, naloxone HCL, nilotinib HCL, propoxyphene HCL, propoxyphene HCL/acetaminophen, propoxyphene HCL/ASA/caffeine, ribavirin/interferon alfa-2B, rosiglitazone/glimepiride, rosiglitazone/metformin HCL, sacrosidase, sibutramine HCL, thalidomide, varenicline tartrate
|
07/17/2013 | |
| Occurrence of Selected Generic Drugs 7 Exploratory Analyses |
albuterol, albuterol sulfate, alvimopan, calcium acetate, chlorambucil, cyclosporine, cyclosporine modified, levalbuterol HCL, levalbuterol tartrate, lindane, phytonadione, solifenacin succinate, tretinoin, vorinostat
|
07/16/2013 | |
| Parkinson’s Disease Medication Use Exploratory Analyses |
carbidopa, combination product of carbidopa, entacapone, levodopa, levodopa and entacapone (Stalevo)
|
06/07/2013 | |
| Oxicam NSAIDs, Modafinil/Armodafinil, Sulfamothoxazole and Severe Cutaneous Adverse Reaction (SCAR) Events Exploratory Analyses |
modafinil, modafinil/armodafinil, oxicam, sulfamothoxazole
|
severe cutaneous adverse reaction (SCAR) |
06/07/2013 |
| Angiotensin Receptor Blockers (ARBs), Hydrochlorothiazide, Atenolol, Amlodipine Use and Celiac Disease Exploratory Analyses |
amlodipine, angiotensin II receptor blocker (ARB), atenolol, candesartan, eprosartan, hydrochlorothiazide (HCTZ), irbesartan, losartan, olmesartan, telmisartan, valsartan
|
celiac disease |
06/07/2013 |
| Occurrence of Selected Pediatric Drugs 1 Exploratory Analyses |
acetaminophen with codeine, acyclovir, albuterol, nizatidine, sucralfate
|
06/06/2013 | |
| Vascular Endothelial Growth Factor (VEGF) Inhibitor Prevalent and Incident Use Exploratory Analyses |
bevacizumab, sorafenib, sunitinib, thalidomide, vascular endothelial growth factor (VEGF) inhibitor
|
05/09/2013 | |
| Dabigatran, Warfarin and GI Bleed, Intracerebral Hemorrhage Exploratory Analyses |
dabigatran, warfarin
|
gastrointestinal hemorrhage , intracerebral hemorrhage (ICH) , serious bleeding |
05/03/2013 |
| Warfarin and GI Bleed, Intracerebral Hemorrhage Exploratory Analyses |
warfarin
|
gastrointestinal hemorrhage , intracerebral hemorrhage (ICH) , serious bleeding |
05/03/2013 |
| Dabigatran, Rivaroxaban, and Warfarin Use Exploratory Analyses |
dabigatran, rivaroxaban, warfarin
|
05/03/2013 | |
| Dabigatran (Pradaxa), Warfarin and Gastrointestinal Bleed, Intracerebral Hemorrhage Safety Analyses |
anticoagulant, blood thinner, Coumadin, dabigatran, Pradaxa, warfarin
|
gastrointestinal hemorrhage , intracerebral hemorrhage (ICH) , serious bleeding |
02/11/2013 |
| Lindane Use Modular Program Exploratory Analyses |
lindane
|
01/10/2013 | |
| Natalizumab, Efalizumab, and Progressive Multifocal Leukoencephalopathy (PML) Exploratory Analyses |
efalizumab, natalizumab
|
progressive multifocal leukoencephalopathy (PML) |
01/10/2013 |
| Selgiline Use Exploratory Analyses |
selgiline
|
01/10/2013 | |
| Bupropion and Naltrexone Use 2 Exploratory Analyses |
bupropion, naltrexone
|
01/09/2013 | |
| Bupropion and Naltrexone Use 1 Exploratory Analyses |
bupropion, naltrexone
|
01/09/2013 | |
| Duloxetine, Pregabalin, and Milnacipran Use 1 Exploratory Analyses |
duloxetine, milnacipran, pregabalin
|
01/09/2013 | |
| Duloxetine, Pregabalin, and Milnacipran Use 2 Exploratory Analyses |
duloxetine, milnacipran, pregabalin
|
01/09/2013 | |
| Clopidogrel and Prasugrel Use Exploratory Analyses |
clopidogrel, prasugrel
|
01/09/2013 | |
| Isoniazid Use Exploratory Analyses |
isoniazid, rifampin/isoniazid, rifampin/isoniazid/pyrazinamid
|
01/07/2013 | |
| Boceprevir and Telaprevir Use Exploratory Analyses |
boceprevir, telaprevir
|
01/07/2013 | |
| Injection Amphotericin Procedures Exploratory Analyses |
injection amphotericin B, injection amphotericin B cholesteryl, injection amphotericin B lipid complex, injection amphotericin B lipid form, injection amphotericin B liposome
|
01/07/2013 | |
| Hip Implant Procedures and Diagnoses 2 Exploratory Analyses |
acetabular component , acquired hemophilia , femoral component , mechanical complication of internal orthopedic device implant and graft , partial hip replacement , total hip replacement |
01/07/2013 | |
| Occurrence of Selected Generic Drugs 6 Exploratory Analyses |
abacavir sulfate, didanosine, didanosine/calcium carb/mag, didanosine/sodium citrate, efavirenz/emtricitab/tenofovir, emtricitabine, emtricitabine/tenofovir, entecavir, lamivudine, stavudine, tenofovir disoproxil fumarate, zidovudine
|
01/07/2013 | |
| Nucleoside Reverse Transcriptase Inhibitor Procedures Exploratory Analyses |
didanosine, injection zidovudine, zidovudine oral
|
01/07/2013 | |
| Amphotericin Use Exploratory Analyses |
amphotericin B, amphotericin B cholesteryl sulfate, amphotericin B lipid complex, amphotericin B liposome
|
01/07/2013 | |
| Occurrence of Selected Generic Drugs 4 Exploratory Analyses |
meloxicam, modafinil, piroxicam, sulfamethoxazole, trimethoprim-sulfamethoxazole
|
12/13/2012 | |
| Golimumab, Ustekinumab, and Dronedarone Hydrochloride Use (by Quarter) Exploratory Analyses |
dronedarone HCL, golimumab, ustekinumab
|
12/13/2012 | |
| Occurrence of Selected Generic Drugs 5 Exploratory Analyses |
alosetron HCL, ambrisentan, bosentan, buprenorphine HCL, eltrombopag olamine, fentanyl, hydromorphone HCL, isotretinoin, lenalidomide, mifepristone, oxycodone HCL, romiplostim, rosiglitazone maleate, rosiglitazone/glimepiride, rosiglitazone/metformin HCL, thalidomide, vigabatrin
|
12/13/2012 | |
| Natalizumab and Efalizumab Use Exploratory Analyses |
efalizumab, natalizumab
|
12/13/2012 | |
| Occurrence of Selected Generic Drugs 3 Exploratory Analyses |
alosetron HCL, ambrisentan, bosentan, buprenorphine HCL, fentanyl, hydromorphone HCL, isotretinoin, lenalidomide, methadone HCL, morphine sulfate, naloxone HCL, oxycodone HCL, rosiglitazone maleate, rosiglitazone/glimepiride, rosiglitazone/metformin HCL, thalidomide
|
12/13/2012 | |
| Golimumab, Ustekinumab, and Dronedarone Hydrochloride Use (by Year) Exploratory Analyses |
dronedarone HCL, golimumab, ustekinumab
|
12/13/2012 | |
| Injection Ustekinumab and Injection Denosumab Procedures Exploratory Analyses |
injection ustekinumab
|
12/13/2012 | |
| Injection Natalizumab Procedures Exploratory Analyses |
injection natalizumab
|
12/13/2012 | |
| Drugs that Act on the Renin-Angiotensin-Aldosterone System (Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Aliskiren) and Angioedema Safety Analyses |
aliskiren, angiotensin II receptor blocker (ARB), angiotensin-converting enzyme (ACE) inhibitor
|
angioedema |
10/18/2012 |
| Occurrence of Selected Generic Drugs 1 Exploratory Analyses |
azathioprine, azathioprine sodium, benzonatate, cabergoline, everolimus, lopinavir/ritonavir, mercaptopurine, ralegravir potassium, ribavirin, ribavirin A-2B, tenofovir disoproxil fumarate, tolvaptan, voriconazole
|
08/30/2012 | |
| Occurrence of Selected HCPCS Codes 1 Exploratory Analyses |
cabergoline oral, combination peginterferon and ribavirin, mercaptopurine oral, negative pressure wound therapy (NPWT)
|
08/30/2012 | |
| Analgesics Use Exploratory Analyses |
analgesic
|
08/02/2012 | |
| Dalfampridine Use Exploratory Analyses |
dalfampridine
|
08/02/2012 | |
| Propylthiouracil and Methimazole Use Exploratory Analyses |
methimazole, propylthiouracil
|
08/02/2012 | |
| Occurrence of Selected Generic Drugs 2 Exploratory Analyses |
acitretin, acitretin/emollient combo. 26, ambrisentan, bosentan, busulfan, chlorambucil, clarithromycin, cyclophosphamide, dronedarone, finasteride, fluconazole, isotretinoin, lenalidomide, lisinopril, lisinopril/hydrochlorothiazide, lithium carbonate, lithium citrate, methimazole, methotrexate, methotrexate sodium, telavancin, thalidomide, topiramate, trastuzumab, valproic acid, warfarin
|
08/02/2012 | |
| Occurrence of Selected HCPCS Codes 2 Exploratory Analyses |
busulfan, chlorambucil, cyclophosphamide, finasteride, methotrexate, trastuzumab
|
08/02/2012 | |
| Infliximab Use Exploratory Analyses |
infliximab
|
08/02/2012 | |
| Injection Infliximab Procedures Exploratory Analyses |
injection infliximab
|
08/02/2012 | |
| Lindane Use Summary Table Exploratory Analyses |
lindane
|
06/22/2012 | |
| Regional Enteritis and Ulcerative Enterocolitis Diagnoses Exploratory Analyses |
Crohn's disease , regional enteritis , ulcerative enterocolitis |
06/22/2012 | |
| Arthritis Diagnoses Exploratory Analyses |
Felty's syndrome , arthritis , inflammatory polyarthropathy , juvenile chronic polyarthritis , rheumatoid arthritis |
06/22/2012 | |
| Clozapine Use Exploratory Analyses |
clozapine
|
06/19/2012 | |
| Use of Vascular Endothelial Growth Factor (VEGF) Inhibitors Exploratory Analyses |
bevacizumab, sorafenib tosylate, sunitinib malate, thalidomide, vascular endothelial growth factor (VEGF) inhibitor
|
06/19/2012 | |
| Bone Resorption Inhibitor Use (by Drug Class) Exploratory Analyses |
bone resorption inhibitor
|
06/19/2012 | |
| VEGF and Bone Resorption Inhibitor Procedures Exploratory Analyses |
bone resorption inhibitor procedure , vascular endothelial growth factor (VEGF) |
06/19/2012 | |
| Negative Pressure Wound Therapy (NPWT) Procedures Exploratory Analyses |
negative pressure wound therapy (NPWT) |
06/08/2012 | |
| Milk Allergy Diagnoses Exploratory Analyses |
milk allergy |
05/11/2012 | |
| Hip Implant Procedures and Diagnoses Exploratory Analyses |
arthroplasty , hemiarthroplasty , hip implant , hip replacement |
05/11/2012 | |
| Cardiopulmonary Resuscitation (CPR) Not Otherwise Specified Procedures Exploratory Analyses |
cardiopulmonary resuscitation (CPR) |
04/26/2012 | |
| Asthma Diagnoses Exploratory Analyses |
asthma |
04/26/2012 | |
| Progressive Multifocal Leukoencephalopathy Diagnoses Exploratory Analyses |
progressive multifocal leukoencephalopathy (PML) |
04/26/2012 | |
| Hyperlipidemia Diagnoses Exploratory Analyses |
hypercholesterolemia , hyperchylomicronemia , hyperglyceridemia , hyperlipidemia |
04/26/2012 | |
| Heart/Lung Resuscitation (CPR), Injection Diphenhydramine Hydrochloride (HCL), Injection Adrenaline Epinephrine Procedures Exploratory Analyses |
injection adrenaline epinephrine, injection diphenhydramine hydrochloride (HCL)
|
cardiopulmonary resuscitation (CPR) |
04/26/2012 |
| Unspecified Allergic Reaction Diagnoses Exploratory Analyses |
unspecified allergic reaction |
04/26/2012 | |
| Acute Myocardial Infarction Diagnoses Exploratory Analyses |
acute myocardial infarction (AMI) |
04/25/2012 | |
| Serious Cutaneous Adverse Reaction (SCAR) Diagnoses Exploratory Analyses |
severe cutaneous adverse reaction (SCAR) |
04/09/2012 | |
| Aseptic Necrosis of Bone Jaw Diagnoses Exploratory Analyses |
aseptic necrosis of bone jaw |
04/09/2012 | |
| Angiotensin II Receptor Blockers and Celiac Disease Exploratory Analyses |
angiotensin II receptor blocker (ARB), candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan
|
celiac disease |
01/16/2012 |
| Smoking Cessation Drugs and Cardiovascular Outcomes Safety Analyses |
bupropion, varenicline
|
acute coronary occlusion without myocardial infarction , acute myocardial infarction (AMI) , cardiovascular outcome , intermediate coronary syndrome , unstable angina |
01/15/2012 |